Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals

Abstract

Background: Dietary magnesium intake has been favorably associated with reduced risk of metabolic outcomes in observational studies; however, few randomized trials have introduced a systemsbiology approach to explore molecular mechanisms of pleiotropic metabolic actions of magnesium supplementation. Objective: We examined the effects of oral magnesium supplementation on metabolic biomarkers and global genomic and proteomic profiling in overweight individuals. Design: We undertook this randomized, crossover, pilot trial in 14 healthy, overweight volunteers [body mass index (in kg/m 2 ) 25] who were randomly assigned to receive magnesium citrate (500 mg elemental Mg/d) or a placebo for 4 wk with a 1-mo washout period. Fasting blood and urine specimens were collected according to standardized protocols. Biochemical assays were conducted on blood specimens. RNA was extracted and subsequently hybridized with the Human Gene ST 1.0 array (Affymetrix, Santa Clara, CA). Urine proteomic profiling was analyzed with the CM10 ProteinChip array (Bio-Rad Laboratories, Hercules, CA). Results: We observed that magnesium treatment significantly decreased fasting C-peptide concentrations (change: 20.4 ng/mL after magnesium treatment compared with +0.05 ng/mL after placebo treatment; P = 0.004) and appeared to decrease fasting insulin concentrations (change: 22.2 lU/mL after magnesium treatment compared with 0.0 lU/mL after placebo treatment; P = 0.25). No consistent patterns were observed across inflammatory biomarkers. Gene expression profiling revealed up-regulation of 24 genes and down-regulation of 36 genes including genes related to metabolic and inflammatory pathways such as C1q and tumor necrosis factorrelated protein 9 (C1QTNF9) and pro-platelet basic protein (PPBP). Urine proteomic profiling showed significant differences in the expression amounts of several peptides and proteins after treatment. Conclusion: Magnesium supplementation for 4 wk in overweight individuals led to distinct changes in gene expression and proteomic profiling consistent with favorable effects on several metabolic pathways. This trial was registered at clinicaltrials.gov as NCT00737815.

Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women

“…Magnesium regulates vascular tone, by influencing formation and release of nitric oxide (NO), and competing against effects of calcium resulting in changes in the vascular smooth muscle tone and contractility [13,14]. In addition, magnesium deficiency has previously been related to oxidative stress, inflammation, endothelial dysfunction, platelet aggregation, insulin resistance and hyperglycemia [15][16][17][18][19] Hypomagnesemia has been shown to negatively influence functional and structural vascular alterations in hypertension [20] but the influence on arterial stiffness…”

An in vivo study on the metabolism and osteogenic activity of bioabsorbable Mg–1Sr alloy

“…It plays essential roles in metabolic pathways as an enzyme catalyst [16,17], in cell structure and function [18,19], and in bone formation and growth by promoting calcium deposition [20,21]. Although Mg is a highly electrochemically active anodic metal [13], advances in metallurgical alloy processing via phase design [13,22] and heat treatment [23] have opened avenues to address the rapid corrosion of Mg in order to meet clinical requirements.…”

Magnesium Intake and Depression in Adults

“…4 Depression and magnesium both are associated with systemic inflammation. 5,6 National data indicate a significant portion of the population has a magnesium intake below the estimated average requirement (EAR). 7 Magnesium supplementation has been linked to improvements in symptoms of major depression, 8 premenstrual symptoms, 9 postpartum depression, 8 and chronic fatigue syndrome.…”